Skip to main content

News Archive

News Archive - School of Medicine

UC San Diego Health Named Center of Excellence for Polycystic Kidney Disease

December 13, 2022

UC San Diego Health has been named a Center of Excellence for polycystic kidney disease (PKD) by the PKD Foundation – the leading advocacy group dedicated to finding treatments and a cure for PKD. UC San Diego Health is one of just 28 institutions nationwide to receive this designation.

New Look at an Ancient Disease: Study Finds Novel Treatment Targets for Gout

December 13, 2022

UC San Diego scientists identify a new molecular model and potential therapeutic target for gout, the most common form of inflammatory arthritis.

UC San Diego Health Recognized for Health Equity in Care of Sickle Cell Crisis

December 12, 2022

UC San Diego Health has been awarded the prestigious 2022 California Association of Public Hospitals and Health Systems Quality Leaders Award in the category of health equity.

CRISPR Technology Improves Huntington’s Disease Symptoms in Models

December 12, 2022

Using models, researchers at UC San Diego School of Medicine, with colleagues elsewhere, describe using RNA-targeting CRISPR/Cas13d technology to develop a new therapeutic strategy that specifically eliminates toxic RNA that causes Huntington’s Disease.

Scientists Receive $4.8M to Pursue Gene Therapy for ‘Incurable’ Disease

December 1, 2022

The California Institute for Regenerative Medicine has awarded UC San Diego researchers $4.8 million to advance a gene therapy to treat Friedreich’s ataxia, a rare but devastating neuromuscular disorder.

Urologists Investigate Climate Change, Health Rights and Gender Equity

November 29, 2022

The Urology for Social Responsibility seminar will be offered in the T. Denny Sanford Center Medical Education and Telemedicine on the UC San Diego campus from January 14 to 15, 2023.

Enzyme Drives Cognitive Decline in Mice, Provides New Target for Alzheimer’s

November 28, 2022

UC San Diego researchers identify the PKCα enzyme as a promising therapeutic target in Alzheimer’s disease; a mutation that increases its activity led to biochemical, cellular and cognitive impairments in mice.

UC San Diego Sanford Stem Cell Institute Launches Stem Cells Into Space

November 22, 2022

The UC San Diego Sanford Stem Cell Institute leads its first space launch, sending stem cells into space aboard the International Space Station. The NASA-partnered study will take advantage of the microgravity environment of space to study accelerated aging in stem cells.

UC San Diego Ranked 8th Globally for Most Influential Researchers

November 22, 2022

The Highly Cited Researchers list identifies and celebrates exceptional researchers who are having a significant impact on the research community as evidenced by the rate at which their work is being cited by their peers. UC San Diego ranks 8th in the world for 2022.

UC San Diego Awarded $8M to Expand Stem Cell Therapy Clinical Trials

November 21, 2022

UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.
Category navigation with Social links